Thyroid Function, Endothelium, and Inflammation in Hemodialyzed Patients: Possible Relations?

Journal of Renal Nutrition

Volumn 17, Issue 1, 2007, Pages 30-37

  Malyszko, Jolanta ^a   Malyszko, Jacek S ^a   Pawlak, Krystyna ^a   Mysliwiec, Michal ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; THYROID HORMONE;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; THYROID GLAND; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; THYROID GLAND; THYROID HORMONES; VASCULAR DISEASES;

EID: 33845765253     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2006.07.003     Document Type: Article

References (30)

1. Lim V.S. Thyroid function in patients with chronic renal failure. Am J Kidney Dis 38 suppl 1 (2001) 80-84
2. Kaptein E.M., Quion-Verde H., Chooljian C.J., et al. The thyroid in end-stage renal disease. Medicine (Baltimore) 67 (1988) 187-197
3. De Groot L.J. Dangerous dogmas in medicine: The nonthyroidal ilness syndrome. J Clin Endocrinol Metab 84 (1999) 151-164
4. Davignon J., and Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109 (2004) III27-III32
5. Malyszko J., Malyszko J.S., and Mysliwiec M. Comparison of hemostasis between CAPD and HD patients. Perit Dial Int 21 (2001) 158-165
6. Malyszko J., Malyszko J.S., and Mysliwiec M. Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis (CAPD). Kidney Blood Press Res 27 (2004) 71-77
7. Malyszko J., Malyszko J.S., Hryszko T., et al. Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathy. Thromb Haemostas 91 (2004) 480-486
8. Yeun J.Y., Levine R.A., Mantadilok V., et al. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35 (2000) 469-476
9. Zoccali C., Benedetto F.A., Mallamaci F., et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 18 (2000) 1207-1213
10. Panichi V., Migliori M., De Pietro S., et al. C reactive protein in patients with chronic renal diseases. Ren Fail 23 (2001) 551-562
11. Stenvinkel P., Heimburger O., Wang T., et al. High serum hyaluronan indicates poor survival in renal replacement therapy. Am J Kidney Dis 34 (1999) 1083-1088
12. Chung S.H., Heimburger O., Stenvinkel P., et al. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 16 (2001) 2240-2245
13. Pecoits-Filho R., Heimburger O., Barany P., et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 41 (2003) 1212-1218
14. Jublanc C., and Bruckert E. Hypothyroidism and cardiovascular disease: role of new risk factors and coagulation parameters. Semin Vasc Med 4 (2004) 145-151
15. Malyszko J., Malyszko J.S., Wolczynski S., et al. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab 89 (2004) 4620-4627
16. Malyszko J., Malyszko J.S., Wolczynski S., et al. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?. Nephrol Dial Transplant 21 (2006) 145-152 Epub 2005 Sep 2
17. Malyszko J., Malyszko J.S., Brzosko S., et al. Markers of endothelial cell activation/injury: CD146 and thrombomodulin are related to adiponectin in kidney allograft recipients. Am J Nephrol 25 (2005) 203-210
18. Zoccali C., Tripepi G., Cutrupi S., et al. Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol 16 (2005) 2789-2795
19. Wiederkehr M.R., Kalogiros J., and Krapf R. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant 19 (2004) 1190-1197
20. van der Poll T., Romijn J.A., Wiersinga W.M., et al. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 71 (1990) 1567-1572
21. Stouthard J.M., van der Poll T., Endert E., et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. Clin Endocrinol Metab 79 (1994) 1342-1346
22. Nagaya T., Fujieda M., Otsuka G., et al. A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome. J Clin Invest 106 (2000) 393-402
23. Cotran R.S., and Pober J. Effects of cytokines on vascular endothelium: their role in vascular and immune injury. Kidney Int 35 (1989) 969-975
24. Sagripanti A., Cozza V., Baicchi U., et al. Increased thrombin generation in patients with chronic renal failure. Int J Clin Lab Res 27 (1997) 72-75
25. Erem C., Ersoz H.O., Karti S.S., et al. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 25 (2002) 345-350
26. Chadarevian R., Bruckert E., Giral P., et al. Relationship between thyroid hormones and fibrinogen levels. Blood Coagul Fibrinol 10 (1999) 481-486
27. Li Y., Chen H., Tan J., et al. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease-indicator of endothelial dysfunction and reduced fibrinolytic capacity. Eur J Clin Invest 28 (1998) 1050-1054
28. Ramsden J.D., Yarram S., Mathews E., et al. Thyroid follicular cells secrete plasminogen activators and can form angiostatin from plasminogen. J Endocrinol 173 (2002) 475-481
29. Lebkowska U., Malyszko J., and Mysliwiec M. Thyroid function and morphology in kidney transplant recipients, hemodialyzed, and peritoneally dialyzed patients. Transplant Proc 35 (2003) 2945-2948
30. Kalantar-Zadeh K., Kilpatrick R.D., Kuwae N., et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 20 (2005) 1880-1888